🇺🇸 FDA
Patent

US 11980607

Methods of treating malignant lymphoproliferative disorders

granted A61KA61K31/407A61K31/433

Quick answer

US patent 11980607 (Methods of treating malignant lymphoproliferative disorders) held by ACTUATE THERAPEUTICS INC. expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ACTUATE THERAPEUTICS INC.
Grant date
Tue May 14 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/407, A61K31/433, A61K31/52, A61K31/53